A rare case of docetaxel‐induced myositis in a patient with a lung adenocarcinoma

Abstract Docetaxel is a cytotoxic taxane frequently used to treat patients with various cancers, including non‐small cell lung cancer (NSCLC). Docetaxel is known to cause acute myalgias, arthralgias, and neuropathy, but there have been few published case reports of myositis. Here, we describe a rare...

Full description

Bibliographic Details
Main Authors: Akane Ishida, Ayumi Ushio, Masao Hashimoto, Satoru Ishii, Go Naka, Motoyasu Iikura, Shinyu Izumi, Masayuki Hojo, Haruhito Sugiyama
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:Thoracic Cancer
Subjects:
Online Access:https://doi.org/10.1111/1759-7714.14480
_version_ 1818163769739575296
author Akane Ishida
Ayumi Ushio
Masao Hashimoto
Satoru Ishii
Go Naka
Motoyasu Iikura
Shinyu Izumi
Masayuki Hojo
Haruhito Sugiyama
author_facet Akane Ishida
Ayumi Ushio
Masao Hashimoto
Satoru Ishii
Go Naka
Motoyasu Iikura
Shinyu Izumi
Masayuki Hojo
Haruhito Sugiyama
author_sort Akane Ishida
collection DOAJ
description Abstract Docetaxel is a cytotoxic taxane frequently used to treat patients with various cancers, including non‐small cell lung cancer (NSCLC). Docetaxel is known to cause acute myalgias, arthralgias, and neuropathy, but there have been few published case reports of myositis. Here, we describe a rare case of docetaxel‐induced myositis diagnosed based on laboratory data, thigh magnetic resonance imaging (MRI), and electromyography (EEG). A 66‐year‐old male was admitted for thigh pain and fatigue that onset 1 week prior. He had been diagnosed with stage IVA (cT4N0M1a) NSCLC 3 years ago and had been started on docetaxel (60 mg/m2 intravenously every 3 weeks; fourth‐line chemotherapy) 1 month earlier. After the second cycle, he developed both thigh pain and fatigue. On admission, his creatinine phosphokinase (CPK) level was elevated, thigh MRI revealed diffuse muscle edema, and EEG showed myogenic changes. We found no plausible cause for myositis except docetaxel. He was diagnosed with myositis and treated with oral prednisolone. His symptoms were relieved and the CPK level declined. Although rare, this case indicates that clinicians should consider the possibility of myositis as a complication in patients on docetaxel.
first_indexed 2024-12-11T16:54:50Z
format Article
id doaj.art-a1d3d3ec82a248158b23efe94d77ce0f
institution Directory Open Access Journal
issn 1759-7706
1759-7714
language English
last_indexed 2024-12-11T16:54:50Z
publishDate 2022-07-01
publisher Wiley
record_format Article
series Thoracic Cancer
spelling doaj.art-a1d3d3ec82a248158b23efe94d77ce0f2022-12-22T00:58:00ZengWileyThoracic Cancer1759-77061759-77142022-07-0113142075207710.1111/1759-7714.14480A rare case of docetaxel‐induced myositis in a patient with a lung adenocarcinomaAkane Ishida0Ayumi Ushio1Masao Hashimoto2Satoru Ishii3Go Naka4Motoyasu Iikura5Shinyu Izumi6Masayuki Hojo7Haruhito Sugiyama8Department of Respiratory Medicine National Center for Global Health and Medicine Tokyo JapanDepartment of Respiratory Medicine National Center for Global Health and Medicine Tokyo JapanDepartment of Respiratory Medicine National Center for Global Health and Medicine Tokyo JapanDepartment of Respiratory Medicine National Center for Global Health and Medicine Tokyo JapanDepartment of Respiratory Medicine National Center for Global Health and Medicine Tokyo JapanDepartment of Respiratory Medicine National Center for Global Health and Medicine Tokyo JapanDepartment of Respiratory Medicine National Center for Global Health and Medicine Tokyo JapanDepartment of Respiratory Medicine National Center for Global Health and Medicine Tokyo JapanDepartment of Respiratory Medicine National Center for Global Health and Medicine Tokyo JapanAbstract Docetaxel is a cytotoxic taxane frequently used to treat patients with various cancers, including non‐small cell lung cancer (NSCLC). Docetaxel is known to cause acute myalgias, arthralgias, and neuropathy, but there have been few published case reports of myositis. Here, we describe a rare case of docetaxel‐induced myositis diagnosed based on laboratory data, thigh magnetic resonance imaging (MRI), and electromyography (EEG). A 66‐year‐old male was admitted for thigh pain and fatigue that onset 1 week prior. He had been diagnosed with stage IVA (cT4N0M1a) NSCLC 3 years ago and had been started on docetaxel (60 mg/m2 intravenously every 3 weeks; fourth‐line chemotherapy) 1 month earlier. After the second cycle, he developed both thigh pain and fatigue. On admission, his creatinine phosphokinase (CPK) level was elevated, thigh MRI revealed diffuse muscle edema, and EEG showed myogenic changes. We found no plausible cause for myositis except docetaxel. He was diagnosed with myositis and treated with oral prednisolone. His symptoms were relieved and the CPK level declined. Although rare, this case indicates that clinicians should consider the possibility of myositis as a complication in patients on docetaxel.https://doi.org/10.1111/1759-7714.14480docetaxellung cancermyositis
spellingShingle Akane Ishida
Ayumi Ushio
Masao Hashimoto
Satoru Ishii
Go Naka
Motoyasu Iikura
Shinyu Izumi
Masayuki Hojo
Haruhito Sugiyama
A rare case of docetaxel‐induced myositis in a patient with a lung adenocarcinoma
Thoracic Cancer
docetaxel
lung cancer
myositis
title A rare case of docetaxel‐induced myositis in a patient with a lung adenocarcinoma
title_full A rare case of docetaxel‐induced myositis in a patient with a lung adenocarcinoma
title_fullStr A rare case of docetaxel‐induced myositis in a patient with a lung adenocarcinoma
title_full_unstemmed A rare case of docetaxel‐induced myositis in a patient with a lung adenocarcinoma
title_short A rare case of docetaxel‐induced myositis in a patient with a lung adenocarcinoma
title_sort rare case of docetaxel induced myositis in a patient with a lung adenocarcinoma
topic docetaxel
lung cancer
myositis
url https://doi.org/10.1111/1759-7714.14480
work_keys_str_mv AT akaneishida ararecaseofdocetaxelinducedmyositisinapatientwithalungadenocarcinoma
AT ayumiushio ararecaseofdocetaxelinducedmyositisinapatientwithalungadenocarcinoma
AT masaohashimoto ararecaseofdocetaxelinducedmyositisinapatientwithalungadenocarcinoma
AT satoruishii ararecaseofdocetaxelinducedmyositisinapatientwithalungadenocarcinoma
AT gonaka ararecaseofdocetaxelinducedmyositisinapatientwithalungadenocarcinoma
AT motoyasuiikura ararecaseofdocetaxelinducedmyositisinapatientwithalungadenocarcinoma
AT shinyuizumi ararecaseofdocetaxelinducedmyositisinapatientwithalungadenocarcinoma
AT masayukihojo ararecaseofdocetaxelinducedmyositisinapatientwithalungadenocarcinoma
AT haruhitosugiyama ararecaseofdocetaxelinducedmyositisinapatientwithalungadenocarcinoma
AT akaneishida rarecaseofdocetaxelinducedmyositisinapatientwithalungadenocarcinoma
AT ayumiushio rarecaseofdocetaxelinducedmyositisinapatientwithalungadenocarcinoma
AT masaohashimoto rarecaseofdocetaxelinducedmyositisinapatientwithalungadenocarcinoma
AT satoruishii rarecaseofdocetaxelinducedmyositisinapatientwithalungadenocarcinoma
AT gonaka rarecaseofdocetaxelinducedmyositisinapatientwithalungadenocarcinoma
AT motoyasuiikura rarecaseofdocetaxelinducedmyositisinapatientwithalungadenocarcinoma
AT shinyuizumi rarecaseofdocetaxelinducedmyositisinapatientwithalungadenocarcinoma
AT masayukihojo rarecaseofdocetaxelinducedmyositisinapatientwithalungadenocarcinoma
AT haruhitosugiyama rarecaseofdocetaxelinducedmyositisinapatientwithalungadenocarcinoma